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TUMOR NECROSIS FACTOR ,6 (TNF-P) INDUCES 
BINDING OF THE NF-KB TRANSCRIPTION 
FACTOR TO A HIGH-AFFINITY KB ELEMENT IN 
THE TNF-@ PROMOTER 
Gerald Messer,‘,* Elisabeth H. Weiss,’ Patrick A. Baeuerle 
The expression of the gene encoding tumor necrosis factor /3 (TNF-P) (lymphotoxin) is induced in 
T cells by various extracellular stimuli. We noticed that most such stimuli also activate the 
NF-KB transcription factor. Here we demonstrate binding of purified human NF-KB to a sequence 
within positions - 98 to -88 (S-GGGGCTTCCCC-3’) of the TNF-P promoter, which is 
conserved between the human and mouse genes. Also the NF-KB from the human T-cell line 
Jurkat, activated upon phytohemagglutinin (PHA)/phorbol 12-myristate 13-acetate (PMA/ 
TPA) treatment in vivo or upon deoxycholate treatment in vitro, binds with high affinity to the 
sequence in the TNF-/3 promoter. Apart from a single mismatch, the site is identical to a 
cis-activating element that is involved in the inducible expression of the MHC class I gene H-2Kb 
and which interacts with both the inducible NF-KB transcription factor and the constitutive 
factor KBFl/H2TFl, as we demonstrate here for the site in the TNF-P promoter. The high 
homology of the well characterized H-2Kb enhancer sequence with the TNF-/3 site with regard to 
sequence and factor binding strongly supports a physiological role for NF-KB in the inducible 
expression of the TNF+ gene. Our observation that the TNF-fi protein can rapidly induce the 
DNA-binding activity of NF-KB in Jurkat T cells and transiently increase TNF-0 mRNA levels 
suggests that NF-KB can mediate a positive autoregulation of TNF-/3 synthesis. 
o 1990 by W.B. Saunders Company. 
Tumor necrosis factor /3 (TNF-/3) is a well charac- 
terized autocrine and paracrine immunoregulatory cy- 
tokine (for reviews see references 1 and 2). It shares a 
high-affinity cell surface receptor with TNF-a3S4 and is 
responsible for mediating cytostatic and cytotoxic ef- 
fects of activated T lymphocytes on neoplastic cells.576 
The expression of the TNF-P gene is induced in CD4- 
positive and CD8-positive T cells upon stimulation by 
antigen, viral infections, T-cell mitogens, and various 
immunomodulatory agents. ‘J Elevated TNF-P expres- 
sion is found in virus-transformed B cells and some B- 
and T-lymphoma cell lines. Cis-activating sequences of 
the TNF-0 gene that confer the inducible and constitu- 
tive modes of transcriptional activation have not yet 
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been characterized. The genes encoding TNF-P and 
TNF-a are situated in tandem within the MHC complex 
in mouse’ and man,8*9 are related in nucleotide sequence, 
and share inducibility by various agents.1,2 TNF-P is 
preferentially expressed in T lymphocytes and TNF-a in 
macrophages. 
Recently, the upstream promoter of the TNF-a 
gene was analyzed. “jl’ Multiple binding sites for the 
NF-KB transcription factor (KB motifs) and so-called 
conserved cytokine motifs (CK-I), which have se- 
quences related to KB motifs, were shown to confer 
inducible transcriptional activation to a reporter gene 
following stimulation of macrophages with lipopolysac- 
charide. The many parallels in the mode of expression of 
TNF-ol and $3 genes1,2*12 and the observation that most 
of the conditions that induce TNF-fl gene expression 
also activate the NF-KB transcription factor, prompted 
us to analyze 5’ flanking sequences of the TNF-P gene 
for potential NF-KB binding sites. 
The ubiquitous NF-KB transcription factor controls 
the inducible expression of a large variety of genes that 
are all involved in immune response and inflammatory 
processes (see Fig. 1B; for reviews see references 13 
and 14). Upon extracellular stimulation of cells, NF-KB 
is rapidly activated by its dissociation from a cytoplas- 
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Figure 1. Potential NF-KB binding sites in the TNF-j3 promoter. 
(A) Position of a highly conserved KB motif in the TNF-P promoter. 
The positions of potential binding sites for NF-KB (KB), Spl, and the 
TATA-factor (T) are shown with regard to the transcription start site 
(+ 1; arrow). The number of the first nucleotide in the boxed sequence 
is given. In the lower part, TNF-P promoter sequences from human25~26 
and mouse2’-24 genes are aligned. In reference 24 (corrected version 
EMBL/GenBank data banks number YOO467), a fifth G residue is 
shown in position -99, as was found in the human promoter. (B) 
Alignment of well studied cis-activating binding sites for the NF-KB 
transcription factor from various genes (for reviews see references 13 
and 14). A consensus motif is shown. U, purines; Y, pyrimidines; N, 
any nycleotide. The gap in the decameric sequences marks the 
symmetry axis. The triangle marks sequences contained within motifs 
of 11 or 12 bp. The asterisks marks the antisense strand of a site. Five 
alignments of decameric sequences from the KB motif of the human 
TNF-@ promoter are shown. Abbreviations: Ig K, immunoglobulin K 
light chain; SV40, simian virus 40; SAA, serum amyloid A; CMV, 
cytomegalovirus. (C) Alignment of the KB motif in the TNF-0 
promoter with a cis-acting NF-KB binding site from the MHC class I 
gene H-2Kb.‘0 Conserved bases are linked by a dash. The single 
mismatch is indicated by an x. 
mic complex with the inhibitory protein IKB.‘~,‘~ Re- 
leased NF-KB can adopt an active heterotetrameric 
composition,17 migrate into the nucleus, and activate 
genes upon binding to KB motifs in enhancer and 
promoter elements. This process is independent of new 
protein synthesis and involves the NF-KB transcription 
factor as a cytoplasmic/nuclear messenger. 
Here, we report the identification of novel binding 
motifs for the NF-KB transcription factor within posi- 
tions -99 to -88 of the TNF-P promoter that are 
recognized with high affinity by the NF-KB activated in 
Jurkat T cells following phytohemagglutinin (PHA) 
phorboll2-myristate 13-acetate (PMA) or TNF-/? treat- 
ment. Also, binding to the TNF-P promoter fragment of 
a second constitutive factor that has characteristics of 
KBFl/H2TFl was observed. The NF-KB binding se- 
quence in the TNF-/3 promoter is highly homologous to 
an element present in the MHC class I gene H-2Kb that 
was previously shown to bind the constitutive factor 
KBFl/H2TFl ‘*,19 or, upon activation of cells, NF- 
KB.~~,*’ The site in the H-2Kb gene was demonstrated to 
function as a bona fide enhancer element that confers 
inducible gene expression following PMA and TNF-a 
treatment of cells.*’ In view of (1) the high-affinity 
binding of NF-KB to the site in the TNF-P promoter, (2) 
the high homology of the TNF-P site to a well character- 
ized cis-activating element of the H-2Kb gene, and (3) 
the increase of TNF-P mRNA in response to almost all 
agents reported to activate NF-KB, we suspect that 
NF-KB is a key regulatory factor in controlling the 
inducible expression of the TNF-fl gene. Considering 
the finding that TNF-P causes the activation of NF-KB 
in T cells and increases TNF-/3 mRNA levels, we discuss 
a possible role for NF-KB in a transient positive autoreg- 
ulation of TNF-/3 synthesis. 
RESULTS 
Sequence-&pecijic Binding of Purified Human 
NF-KB to the TNF-@ Promoter 
We have sequenced 2 kb of the 5’ portion of the 
human TNF-0 gene and found allelic polymorphism 
that is in linkage disequilibrium with certain MHC 
haplotypes. ” By inspection, we noticed binding motifs 
for the NF-KB transcription factor between positions 
-99 to -88 of the human TNF-/3 promoter that are 
conserved in the mouse promoter22-24 with respect to 
sequence and distance to the transcription start site 
(Fig. lA,B). Sequences flanking the putative site were 
not highly conserved. A comparison of the KB motif from 
the TNF-P promoter with known functional KB motifs is 
shown in Fig. 1B. It is intriguing that the TNF-P site 
mismatches in only one base pair within positions -98 
to -89 with a motif found in the MHC class I gene 
H-2Kb “‘*’ (Fig. 1C). The latter allows binding of the 
NF-KB transcription factor and of factors called KBFl 
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and H2TFl and was shown to function in c&-activating 
a reporter gene upon PMA and TNF-a stimulation of 
cells, even in the absence of the in situ flanking se- 
quences. ” Hence, the seq uence conservation between 
the H-2Kb and TNF-P promoters is precisely restricted 
to a sequence that is sufficient to confer inducible 
transcriptional activation. 
To assess whether NF-KB can bind to the putative 
site(s) in the TNF-/3 promoter we performed a methyla- 
tion interference analysis using purified human NF-KB 
consisting of 50-kDa and 65-kDa protein subunits17 . As 
expected, methylation of almost all purines on sense and 
antisense strands within the dodecameric sequence inter- 
fered strongly with binding of NF-KB (Fig. 2A). Meth- 
ylation of the guanosine residue in position - 99 showed 
a weaker but still significant inhibitory effect on NF-KB 
binding. The binding study with the TNF-P promoter 
fragment thus reveals a series of novel KB motifs that 
vary only within positions 4 to 8 encompassing the less 
conserved part of the KB consensus motif (Fig. 1 B). 
High-Afinity Binding of NF-KB Activated in 
T Cells to the TNF-p Promoter Fragment 
To investigate whether the TNF-P promoter frag- 
ment can detect the NF-KB activated in a physiological 
system, we stimulated human Jurkat T cells with 
PHA/PMA, a condition that mimics T-cell activation,27 
induces binding of NF-KB in T cells to KB motifs of the 
human immunodeficiency virus 1 (HIV-1),28 interleukin 
2 receptor (IL2R),2g and granulocyte-macrophage col- 
ony-stimulating factor (GM-CSF)30 upstream promoter 
elements and increases TNF-/? mRNA levels. (See 
Activation of NF-KB in Jurkat T Cells by TNF-/3.) 
In extracts from T cells, the TNF-P DNA probe 
detected a DNA-binding activity that showed all the 
characteristics of NF-KB (Fig. 3). The activity was 
hardly detectable in unstimulated T cells (Fig. 3A, lane 
1) but was strongly induced upon PHA/PMA stimula- 
tion (Fig. 3A, lane 3). Its protein-DNA complex comi- 
grated with that of purified human NF-KB (Fig. 3B, lane 
1) and its formation was specifically competed for by a 
25-fold molar excess of unlabeled oligonucleotides con- 
taining KB motifs of the mouse K light chain enhancer33 
(Fig. 3B, lane 6) and the interleukin 2 enhancer34 (Fig. 
3B, lane 9), but not by an unrelated oligonucleotide 
(Fig. 3B, lane 11). 
The TNF-/3 promoter fragment was also recognized 
by NF-KB that was activated in vitro by treatment of 
cytosolic fractions from Jurkat T cells with deoxycholate 
(DOC) (Fig. 3C, lanes 2 and 4). This treatment specifi- 
cally activates a cytosolic form of NF-KB by releasing 
IKB, an inhibitory protein, that is responsible for the 
inactivation and cytoplasmic localization of the NF-KB 
transcription factor. l6 When the T-cell extracts were 
analyzed in electrophoretic mobility shift assays 
(EMSAs) with a radioactively labeled DNA probe 
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Figure 2. Sequence-specific binding of purified NF-KB to a TNF-8 
promoter fragment. 
(A) For the methylation interference analysis, purified NF-KB from 
human placenta was reacted with partially methylated TNF-fi pro- 
moter fragments end-labeled on antisense (left panel) or sense strands 
(right panel), followed by separation of free and complexed DNA on a 
native gel. A purine ladder (Pu}, was coelectrophoresed with the 
samples. Filled arrowheads indicate purine residues that strongly 
interfered with NF-KB binding when methylated. The half-filled 
arrowhead indicates partial interference. (B) Summary of the meth- 
ylation interference data. Purine residues crucial for NF-KB binding 
are indicated with a filled dot. A guanosine residue less required for 
protein binding is labeled with a half-filled dot. Three decameric 
frames representing the minimal NF-KB binding site are shown on top. 
encompassing the two KB motifs from the HIV-l 
enhancer,28 a pattern of DNA-binding activities was 
seen that was almost identical to that obtained with the 
TNF-P DNA probe (compare Fig. 4A with Fig. 3A and 
3C). The only significant difference was the presence of 
an additional faster-migrating DNA-binding activity 
detected only with the TNF-P and H-2Kb probes (see 
Fig. 4). 
To estimate a relative affinity of NF-KB for the 
TNF-/3 site(s) in comparison to two physiologically 
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Figure 3. Specific and high-affinity binding of NF-KB activated in Jurkat T cells to a TNF-j3 promoter fragment. 
Nuclear extracts (N) and cytosol (C) were prepared from control cells (-) and cells that were treated for 4 hr with 
a combination of 50 ng/mL PMA and 5 &mL PHA (+). (A) Detection of NF-KB activated by mitogen- 
stimulation of T cells using a labeled TNF-fi promoter fragment. The filled arrowhead indicates the position of a 
NF-kB/DNA complex and the arrow that of a complex formed by KBFl/H2TFl. The open arrowhead indicates 
the position of uncomplexed DNA probe. (B) Competition analysis. In lane 1, a comigration of purified NF-KB (50 
pg) from human placenta is shown. A nuclear extract (N) containing mitogen-activated NF-KB (+) was used for 
the competition analysis (lanes 2-12). Molar excesses of 2.5- (lanes 2, 5, and 8), 25- (lanes 3, 6, 9, and 11) and 
250-fold (lanes 4, 7, 10, and 12) of unlabeled oligonucleotide were included in binding reactions with the labeled 
TNF-/3 oligonucleotide. Lanes 2-4, competition with increasing amounts (filled slopes) of an homologous TNF-@ 
oligonucleotide (see Fig. 1B); lanes 5-7, a 34-mer” encompassing sequences from the mouse K light chain enhancer 
(KB) with the KB motif 5’-GGGACTTTCC-3’33; lanes 8-10, a 34-me?’ encompassing sequences from the human IL 
2 enhancer (IL-2) with the KB motif 5’-GGGATTTCAC-3’34, lanes 11 and 12, competition with an unrelated 
oligonucleotide. (C) Binding of DOC-activated NF-KB to the TNF-fi probe. 
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Figure 4. Detection of a KBFl/H2TFl-like binding 
activity with a fragment from the H-2Kb promoter. 
For details of illustration see legend to Fig. 3. (A) 
Analysis of Jurkat T cell extracts with a labeled 
HIV-l enhancer fragment. A 50-mer oligonucleotide 
encompassing the two KB motifs of the HIV-l 
enhancer” was used. (B) Analysis of Jurkat T-cell 
extracts with a labeled H-2Kb enhancer fragment. A 
39-mer oligonucleotide was used encompassing the KB 
motif of the MHC class I H-2Kb gene’9,20 with 14 (5’ 
end) and 10 (3’ end) bp of original flanking sequence 
and Hind111 and Sal1 linker sites the on 5’ and 3’ ends, 
respectively. 
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relevant cis-acting KB motifs we performed a titration 
with 2.5, 25, and 250-fold molar excesses of unlabeled 
competitor oligonucleotides (Fig. 3B). Strongest inhibi- 
tion of NF-KB binding to the TNF-fl probe was obtained 
with the KB site 5’-GGGACTTTCC-3’ from the murine 
K light chain enhancer33 (Fig. 3B, lanes 5-7). Homolo- 
gous competition with unlabeled TNF-P oligonucleotide 
was about two- to three-fold less efficient (Fig. 3B, lanes 
2-4). It was, however, more effective than competition 
with an oligonucleotide containing the KB motif 5’- 
GGGATTTCAC-3’ from the interleukin 2 (IL 2) en- 
hancer, which is functional in conferring transcriptional 
activation in response to T-cell-activating signals.34 An 
unrelated oligonucleotide could not compete, even at a 
250-fold molar excess over the radioactive probe (Fig. 
3B, lane 12). The finding that the site(s) from the 
TNF-/3 promoter competed better for the DNA binding 
of NF-KB than did the IL 2 enhancer site suggests that 
the affinity with which NF-KB binds to the TNF-P 
promoter is sufficiently high to be of significance for the 
inducible expression of the TNF-P gene. 
Binding of a KBFl /H2TFl -Like Factor to the 
TNF-/3 Promoter 
The TNF-P oligonucleotide detected a second spe- 
cific DNA-binding activity in extracts from unstimu- 
lated and stimulated Jurkat T cells (Fig. 3A and B). 
Because the TNF-@ site is highly homologous to a site 
found in the H-2Kb class I gene (Fig. lC), we suspected 
that the additional DNA-binding activity was KBFl/ 
H2TFl. As has been reported for KBF1,35 this DNA- 
binding activity was constitutively present and gave rise 
to a protein-DNA complex that migrated faster in 
native polyacrylamide gels than the one formed by 
NF-KB (Fig. 3A, lane 1). The DNA-binding activity was 
specific for the TNF-P probe, since a 25-fold molar 
excess of unlabeled TNF-/3 oligonucleotide completely 
inhibited binding (Fig. 3B, lane 3) but a 250-fold molar 
excess of the unrelated oligonucleotide did not (Fig. 3B, 
lane 12). 
The oligonucleotides containing KB motifs from the 
mouse K light chain and IL 2 enhancer also inhibited 
binding of the factor to the TNF-/3 probe, but less 
efficiently by at least one order of magnitude (Fig. 3B, 
lanes 5-10). A lower affinity for the mouse K enhancer 
motif compared to the H-2Kb motif was also observed 
for the KBFl/H2TFl factor.‘9’36 The KBFl/H2TFl- 
like DNA-binding activity was not detected when T-cell 
extracts were examined with a DNA probe encompass- 
ing the two KB motifs from the HIV-l enhancer, which 
gave an otherwise identical pattern of bands (compare 
Figs. 3A and 4A). The KB motifs from the HIV-l 
enhancer are identical with that from the mouse K light 
chain enhancer and should not strongly bind KBFl/ 
H2TFl ,19,36 
To substantiate that the additional DNA-binding 
activity detected by the TNF-0 promoter fragment was 
indeed KBFl/H2TFl we performed EMSAs with an 
oligonucleotide that contained the sequence from the 
H-2Kb enhancer encompassing the KB/KBF~ /H2TFl 
binding motif. In contrast to the HIV-l enhancer (Fig. 
4A), a radioactively labeled H-2Kb DNA probe indeed 
gave rise to a faster-migrating protein-DNA complex 
with the same mobility as that seen with the TNF-P 
probe (Fig. 4B, lane 1). Moreover, the pattern of 
DNA-binding activities detected with the H-2Kb probe 
in nuclear extracts of T cells was very similar to that 
detected with the TNF-/3 probe (compare Figs. 3A,C 
and Fig. 4B), although with the H-2Kb probe two 
DNA-binding activities in cytosolic fractions were ob- 
served that had mobilities slightly distinct from those of 
NF-KB and KBFl/H2TFl (Fig. 4B, lane 2). 
Our data suggest that the KB elements from the 
H-2Kb enhancer and the TNF-P promoter are identical 
with regard to binding of NF-KB and KBFl/H2TFl. 
Therefore, they are most likely also similar or identical 
with respect to their cis-activating potential. In numer- 
ous instances it has been shown that binding of NF-KB to 
KB motifs confers a typical transcriptional responsive- 
ness to genes.13j14 In that sense, we have noticed that 
most, if not all, of the various agents that activate NF-KB 
DNA binding in T cells also induce TNF-8 gene 
expression (or increase TNF-/3 mRNA levels) (Table 1). 
Activation of NF-KB in Jwkat T Cells by TNF-p 
In Jurkat T cells, TNF-a induces activation of 
NF-KB and transiently increases TNF-6 mRNA levels. 
TABLE 1. Agents that increase TNF-8 mRNA levels and 
that activate the DNA-binding activity of NF-KB 
Agents tested for stimulating TNF-P transcription’.’ and agents 
activating NF-kB ‘W have recently been reviewed. Not discussed were 
the effects of TNF-/3 (this paper), and the following references have 
also been used: activation of TNF-P transcription by anti-CD28/ 
CD3,37,38 and HTLV-I;39.40 activation of NF-kB by anti-CD28/CD3.4’ 
n.t., not tested. 
Stimulus 
Induction of TNF-P Activation of NF-KB 
messenger RNA DNA binding 
TNF-ol + + 
TNF-P + + 
IL 1 + + 
antigen + + 
anti-CD28,-CD3 -t + 
Lectins + + 
Phorbol esters + + 
Calcium ionophore + + 
UV light n.t. + 
Poly(r1). Poly(rC) + + 
HTLV-I + + 
HIV-l + n.t. 
Herpes simplex virus -2 + + 
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Recent reports have shown that TNF-a, can induce the 
activation of NF-KB~*-~~ but similar studies with TNF-P 
have not yet been reported. Jurkat T cells were incu- 
bated for 30 min at a concentration of 60 pM human 
TNF-P or 60 pM human TNF-(r. Nuclear extracts and 
cytosolic fractions were then assayed for the DNA- 
binding activity of NF-KB by EMSA using a labeled 
TNF-@ promoter fragment (Fig. 5, lanes l-7). Com- 
pared to control cells (Fig. 5, lane 2), both cytokines 
induced a strong accumulation of newly activated DNA- 
binding activities in the nucleus (Fig. 5, lanes 4 and 6). 
One complex induced by TNF-/3 comigrated with that 
induced by TNF-(U (Fig. 5, lane 4), the complex acti- 
vated in cytosolic fractions by DOC (data not shown), 
and with that of purified human NF-KB (Fig. 5, lane 1). 
The activation was specific for TNF-P, since a treatment 
of Jurkat cells with the same volume of buffer containing 
ten times less TNF-/3 had no effect (data not shown). 
The same DNA-binding activity was detected by a 
DNA-probe encompassing sequences from the IL2R 
a-chain enhancer containing the KB element (Fig. 5, 
lanes 8-14). In fractions from TNF-treated cells, a 
second, faster-migrating band was seen that presumably 
corresponded to a proteolytically truncated form of 
NF-KB described earlier. l7 By all these criteria, it was 
the NF-KB transcription factor that was rapidly acti- 
vated in T lymphocytes upon TNF-fl treatment. 
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Figure 6. Induction of TNF-@ mRNA by TNF-P stimulation of 
Jurkat T cells. 
Jurkat cells were treated with 800 U/mL human recombinant TNF-P 
(lanes 2-5), or 800 U/mL TNF-cu (lanes 6-8) (both Genzyme, USA) 
and with 50 ng PMA/5 pg PHA per mL (lanes 9-l 1) for 4 hr (lanes 2, 
6 and 9), 12 hr (lanes 3,7 and lo), and 24 hr (lanes 4,s and 11). Lane 
1, control. Lane 5, TNF-/3 stimulation of 12 hr, preincubated with 
monoclonal antibody 9B9, neutralizing TNF-P activities (BASF, 
Ludwigshafen). The upper panel shows an autoradiogram of a nylon 
Hybond-N (Amersham, USA) filter. The filled arrowhead indicates 
the oosition of a 1.35-kb TNF-a-soecific mRNA signal. The lower 
panel shows a section of the agarbse gel containing the-2% RNA after 
ethidium bromide staining. 
We tested by Northern blot analysis whether TNF-P 
treatment can induce TNF-P mRNA in the Jurkat 
T-cell line (Fig. 6, Table 1). While TNF-P mRNA was 
barely detectable in unstimulated cells (Fig. 6, lane l), 
1.33 nM TNF-P in the medium rapidly induced a 
maximal increase of its RNA within 4 hr. After 12 and 
24 hr (Fig. 6, lanes 3 and 4) the signal declined. 
Preincubation of TNF-/3 with the TNF-P-specific mono- 
clonal antibody 9B9 prevented TNF-P mRNA induc- 
tion (Fig. 6, lane 5). Stimulation of Jurkat cells with 1 .O 
nM TNF-cr resulted in a stronger increase of TNF-P 
mRNA with the same kinetics of a decrease after 12 and 
24 hr (Fig. 6, lanes 6-8). In contrast to this transient 
stimulation with both cytokines, PMA/PHA treatment 
resulted in a steady accumulation of mRNA over the 
test period (Fig. 6, lanes 9- 11). 
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Figure 5. Activation of NF-KB by TNF+3. 
Jurkat T cells were treated for 30 min with 60 pM 
TNF-LU (lanes 4, 5, 11 and 12), 60 pM TNF-fi (lanes 
6, 7, 13 and 14), or left untreated (Co) (lanes 2, 3, 9 
and 10). Nuclear extracts (N) and cytosolic fractions 
(C) were tested for NF-KB activity in EMSAs using a 
labeled TNF-fl promoter fragment (lanes l-7) and a 
fragment” of the IL2R a-chain enhancer encompass- 
ing-the KB motif (lanes 8-14). The open arrowheads 
indicate the position of unbound DNA Drobe and the 
filled arrowheads the position of an ‘NF-KB-DNA 
complex. 
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DISCUSSION 
The finding that in the Jurkat T cell line TNF-P 
treatment of cells increases both NF-KB DNA binding 
and TNF-P mRNA levels suggests an involvement of 
NF-KB in a transient positive autoregulation of TNF-P 
synthesis. It appears that TNF-P can induce its own 
synthesis by using NF-KB as a cytoplasmic/nuclear 
messenger and transcriptional activator. 
This study shows that the NF-KB transcription 
factor can bind with high affinity and specificity to a 
conserved 12-bp sequence located about 95 bp upstream 
of the transcription start site of the TNF-P gene. 
Binding was demonstrated with NF-KB from PMA/ 
PHA-stimulated T cells, NF-KB activated in cytosolic 
fractions by treatment with DOC, and with highly 
purified NF-KB from human placenta. 
The following observations suggest a role of the 
interaction of NF-KB with the TNF-fl promoter site in 
the control of transcription initiation of the TNF-P gene: 
(1) The binding of NF-KB to the TNF-fl site(s) is of high 
affinity. In fact, it was better than binding of NF-KB to a 
KB motif in the IL 2 enhancer, which was shown 
previously to be cis-activating.34 In all cases reported so 
far, constructs containing isolated high-affinity binding 
sites for NF-KB were able to confer transcriptional 
activation to reporter genes when sites were multimer- 
ized or placed in single copies close to a promoter.‘3Y14,45*46 
(2) The site identified in the TNF-P gene is, apart from a 
single mismatch, identical to a well characterized cis- 
activating element found in the H-2Kb gene. The mis- 
match lies within the non-conserved center of the KB 
motif (Fig. 1C) and, as is obvious from our data, has no 
significant influence on binding of NF-KB or KBFl/ 
H2TFl-like factors. The H-2Kb motif 5’-GGGGATTC- 
CCC-3’ was recently analyzed in the absence of its in 
situ flanking sequences and shown to confer, in multi- 
merized form, induction of gene expression following 
stimulation of transfected cells with TNF-or and PMA.” 
(3) NF-KB can be activated by a diverse spectrum of 
agents and thereby can confer transcriptional activation 
in response to many different stimuli13”4 (see Table 1). 
We observed a striking overlap between agents that 
induce NF-KB binding activity and those that lead to an 
increase of TNF-/3 mRNA levels. Table 1 lists 13 agents 
that were tested for their effects on NF-KB activation 
and/or TNF-P transcription. Out of 12 agents found to 
activate NF-KB in T cells and in a great variety of cell 
types, 11 were also found to increase TNF-/3 mRNA 
levels in T cells, T-cell-derived lines, and B-cell lines.1*2 
The effects of UV light have not yet been tested for 
TNF-@ mRNA induction (Table 1). It is interesting to 
note that TNF-P is constitutively expressed in HTLV-I- 
infected T-cells.3g’40 Upon HTLV-I infection of cells, 
NF-KB becomes constitutively activated through the 
Tax, protein of the virus47,48 and can thereby provide 
constitutive transcriptional initiation to genes that are 
controlled by cis-acting KB motifs. NF-KB is unlikely to 
be responsible for a cell type-specific expression of the 
TNF-/3 gene. Rather NF-KB serves to rapidly initiate 
transcription following extracellular stimulation of cells. 
It is likely, however, that NF-KB can synergize with cell 
type-specific factors. Only a deletion analysis of the 
TNF-P promoter and other sequences surrounding the 
gene can clarify this issue. 
TNF-P adds to an increasing number of cytokine 
genes that are likely to be regulated by the NF-KB 
transcription factor. Other examples are the p-inter- 
feron4g*50 IL 2 34 IL 6 51~52 TNF-a l”,ll and GM-CSF 
genes. 3o Not only are m an c y y tokine genes activated by 
NF-KB, but NF-KB itself is activated by at least two 
distinct cytokines, TNF-a and IL 1.42,43 Here we show 
that picomolar amounts of the TNF-P protein, which 
presumably shares high affinity cell surface receptors 
with TNF-01,3Y4 can rapidly induce the DNA-binding 
activity of NF-KB. Thus, in the case of both TNFs, 
NF-KB appears to be involved in a transient positive 
autoregulation. The transcription factor emerges as a 
central signaling molecule in cytokine networks that 
allows coupling of cytokine stimulation of cells to the 
new synthesis of cytokines. Because NF-KB is rapidly 
activated through a simple dissociation reaction and 
can actively participate in cytoplasmic/nuclear signal- 
ing, 15,16*53 it is particularly suitable to translate cytokine 
stimuli into new patterns of gene expression and, subse- 
quently, into the synthesis of new effector proteins. 
MATERIALS AND METHODS 
Cell Lines and Culture 
The T-cell line Jurkat was grown in RPMI-1640 medium 
supplemented with 10% fetal calf serum (both Gibco). Cells 
were tested negative for mycoplasma using bisbenzimid H 
33258 (Riedel-de Haen). Stimulation with 5 Mg/mL PHA 
(Sigma) and 50 ng/mL PMA (Sigma) was performed for 4 hr 
and treatment with 60 pM recombinant human TNF-(U or 
TNF-/3 (both BASF, Ludwigshafen) for 30 min. Cells were 
harvested by centrifugation for 10 set at 1OOOg and washed in 
ice-cold PBS, and the cell pellets obtained after recentrifuga- 
tion were lysed in hypotonic buffer A.54 Protein concentrations 
were determined with the BioRad Microassay. 
Oligonucleotides 
Oligonucleotides were synthesised by the phosphora- 
midite method on an Applied Biosystems DNA synthesizer. 
The KB motifs were placed such that after annealing of single 
strands the NF-KB binding site was in the center of the probes 
flanked by 5 to 10 bp of original sequence and Hind111 and 
Sal1 linker sites on 5’ and 3’ ends, respectively. For EMSAs, 
annealed oligonucleotides were labeled with [c~-~*P]~CTP 
(Amersham) by the Klenow enzyme (Boehringer). After 
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labeling, the double-stranded oligonucleotides were extracted 
from melted agarose by phenol/chloroform, precipitated in 
70% ethanol, and used after dissolving in 10 mM Tris-HCl, pH 
7.5,0.5 mM EDTA. 
To avoid possible annealing artifacts with the GC-rich 
TNF-fl oligonucleotide, labeling was performed in a thermocy- 
cler (Hybaid). The two single-stranded TNF-/3 oligonucle- 
otides were denatured for 2 min at 94OC in 50 ~1 of a 
polymerase chain reaction standard mix containing 1 mM 
MgCl,, 5 pmoles of each of the three unlabeled dNTPs, and 5 
pmoles of [a-32P]dCTP (Amersham). 1.6 U of Taq DNA 
polymerase (United States Biochemical) was added and the 
reaction cooled to 72OC over a period of 20 min. The DNA 
probe was purified on a non-denaturing 12% polyacrylamide 
gel. The unrelated oligonucleotide (unr) used in competition 
experiments was derived from the plasmid pKK 223-3 (Phar- 
macia) and encompassed 56 bp upstream of the EcoRI site of 
the polylinker. 
Electrophovetic Mobility Shift Assays 
Conditions were essentially as described earlier.‘5’30 Acti- 
vation of the cytoplasmic form of NF-KB was performed by 
adding 2.5 ~1 of a 4% solution of DOC (deoxycholate) to 
cellular fractions followed by addition of a DNA-binding 
reaction mixture” and 2 ~1 of a 10% (v/v) solution of Nonidet 
P-40 (Sigma). 
Nuclear extracts and cytosolic fractions were prepared 
from control and stimulated Jurkat cells and equal portions of 
fractions (2 ~1; l-3 pg of protein) were reacted with a 
radiolabeled KB oligonucleotide (0.1 ng per reaction) and 
samples analyzed by EMSA as described.30 Autoradiograms 
of native 4% polyacrylamide gels are shown. 
Methylation Interference Analysis 
The TNF-P promoter oligonucleotides, sense and an- 
tisense strands, encompassing a sequence from position - 111 
to -79 (referred to as TNF-@ probe) were end-labeled with 
‘*P using polynucleotide kinase (Boehringer) and reacted with 
purified human NF-KB’~ (approximately 0.5 ng) in a lo-fold 
scaled-up EMSA DNA-binding reaction, Complexed and free 
DNA were separated on a 4% native polyacrylamide gel, 
transferred onto DEAE paper by semi-dry blotting, and 
further processed as described elsewhere.30 
Analysis of mRNA Levels 
Ten micrograms of total RNA extracted from stimulated 
and unstimulated Jurkat T cells according to Chirgwin et a1.31 
was electrophoresed on a 1.2% denaturing formaldehyde 
agarose gel and transferred onto a nylon filter. The TNF-P 
mRNA was detected by hybridization according to the proto- 
col of Church and Gilbert,32 using a human genomic 600-bp 
PvuII/PstI TNF-P fragment containing sequence of exon 4 
and the 3’ untranslated region.*l 
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